Bionaturis contributes in the MAB’s take off year

2013 will go down into history of the recently founded Alternative Spanish Stock Market (MAB) as the year in which it confirmed its take off increasing the trading volume by five fold. According to statistics published by BME, it has reached 279 million € in volume and 87 million of stock transactions.

The 23 companies listed on the MAB –among them, Bionaturis- have raised 45 million euros in the market, +12% from 2012. Last year, there were 13 capital increases and the number of trades increased by eight fold. The overall market capitalization at the end of 2013 reached 1.677 million euros, three times more than in the previous year.

The specialized media Cinco días claims Carbures as the company that has registered the top performance in the past year with 710% increase. It has been followed by other companies, accounting Gowex (nearly 500%), Ebios (148%) and Bionaturis itself, ended up the year with a global 110% rise.

2014 for the MAB has begun in an encouraging way in their first sessions, while companies are willing to continue breaking records.

At the begining of the new year, let’s go over the main events for Bionaturis during 2013

As it was forecasted in the business plan, 2013 has been full of activity for Bionaturis, with a much than positive balance in a key area for our business model: the relationship with multinational companies. Thus, during last year Bionaturis has released the signing of three contracts with important veterinarian multinational companies to test its vaccines, such as the one intended to prevent the most devastating diseases of salmons, or the unique vaccine that fight helmints infections in livestock. These agreements have confirmed its position as a global supplier of biological vaccines.

This remarkable position was endorsed in September with the organization, along with “Corporation Tecnologica de Andalucia”, of the Biotech Technical Committee. The event, gathering managers of large laboratories and international experts in the field, was part of the Flylife’s gala day, a manufacturing facility showing one of the highest ratio of biological product production by square meter currently in the market.

In the institutional side, we also highlight that the prestigious Forbes magazine in its last March edition named our CEO, Victor Infante, as one of the 25 young businessmen in Spain to be tracked. Later, in October, he was invited to the extraordinary executive committee of the “Confederation Empresarios de Cadiz”, being chaired by in this special occasion by His Royal Highness Prince Felipe de Asturias, where Infante explained to the attendees the principles, mission and vision of Bionaturis.

2013 has also brought striking news for our investors, ending up the year with a +110% of the annual share price and a remarkable increase of the daily trading volume. That situation has led the BNT-MAB titles to be included in different proposals of investment portfolios for 2014 and it is considered one of the […]

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.